Rapid Micro Biosystems raises FY24 revenue view to $28.1M from at least $27M

Consensus $27.45M. The company said, “The Company expects full year 2024 revenue of approximately $28.1 million, representing growth of approximately 25% compared to the prior year. It placed 21 new systems and completed the validation of 16 customer systems during 2024. The Company plans to announce complete financial results for the fourth quarter and full year 2024 and host a webcast to discuss those results as well as its 2025 outlook later in the first quarter of 2025. The preliminary financial results described herein have not been audited and are subject to adjustment based on the Company’s completion of year-end financial close processes.”